Epic Research Update : Claris Lifesciences

Claris Lifesciences has received the Abbreviated New Drug Application (ANDA) approval for Furosemide Injection in the United States of America (US). This product will be sold in 10 mg/ml formulation packed in 20mg/2ml, 40mg/4ml and 100mg/10ml single dose vials having approximately market size of $22 million.

For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI

Posted in: Indian Market Tips